Table 3.1:
Summary of Sample Characteristics (n=180)
Emetogenicity | |
Highly-emetogenic (HEC) | 127 (70.6%) |
Moderately-emetogenic (MEC) | 53 (29.4%) |
Chemotherapy type | |
Carboplatin | 12 (6.7%) |
Cisplatin | 34 (18.9%) |
Dacarbazine | 12 (6.7%) |
Dactinomycin | 21 (11.7%) |
Other HEC | 48 (26.7%) |
MEC | 53 (29.4%) |
Cancer type | |
Solid tumor | 73 (40.6%) |
Lymphoma | 48 (26.7%) |
CNS | 16 (8.9%) |
Leukemia | 43 (23.9%) |
Cancer status | |
First occurrence | 153 (85%) |
Relapse | 27 (15%) |